• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cardiome Pharma Corp

+ Add to Watchlist

CRME:US

9.0400 USD 0.0900 0.99%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Cardiome Pharma Corp (CRME)

Open: 9.4500 Day's Range: 9.0400 - 9.4900 Volume: 136,072
Previous Close: 9.1300 52wk Range: 5.8405 - 11.0000 1-Yr Rtn: +44.64%

Stock Chart for CRME

No chart data available.
  • CRME:US 9.0400
  • 1D
  • 1M
  • 1Y
9.1300
Interactive CRME Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CRME

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.8570
Est. PEG Ratio -
Market Cap (M USD) 149.35
Shares Outstanding (M) 16.52
30 Day Average Volume 51,782
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CRME

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CRME

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with clinical drug programs. The Company's programs focus on atrial arrhythmia and congestive heart failure.

William L Hunter "Bill"President/CEOJennifer ArchibaldChief Financial Officer
Karim LaljiChief Commercial OfficerSheila M GrantChief Operating Officer
More Company Profile & Key Executives for CRME

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil